Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data Update – Slideshow (NASDAQ:ROIV) 2026-04-04
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development[……] Read More